Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Pharma
Merck’s Welireg combo nabs FDA nod to expand kidney cancer reach
Analysts have projected rapid uptake for Welireg in second-line kidney cancer based on data from a phase 3 trial and doctors’ feedback.
Angus Liu
Sep 25, 2026 11:30am
Failed Trodelvy first-line NSCLC trial shows better China data
Sep 12, 2026 9:45pm
Merck to lay off another 54 at New Jersey HQ
Sep 9, 2026 11:10am
Fierce Biotech
A year after Big Pharma’s pull-back from the UK, what’s changed?
Sep 4, 2026 10:00am
Merck charts long-term path for first PCSK9 pill
Aug 4, 2026 2:38pm
Legend Biotech, Merck, Otsuka—Fierce Pharma Asia
Jul 31, 2026 9:00am